Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
SPDR S&P Pharmaceuticals ETF (XPH) and Invesco S&P SmallCap Health Care ETF (PSCH) belong to the same industry segment: US Health Care. Both ETFs have the same top 3 sector exposures: and Health Care. XPH is more expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.29% for PSCH. XPH is down -4.43% year-to-date (YTD) with +$88M in YTD flows. PSCH performs worse with -9.57% YTD performance, and -$14M in YTD flows. Run a side-by-side ETF comparison of XPH and PSCH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | XPH PSCH | -5.57%-4.98% | -4.40%-13.47% | -4.43%-9.57% | +25.72%-4.84% | +38.19%-5.55% | +4.97%-37.27% |
| Flows | XPH PSCH | +$12M-$12M | +$95M-$15M | +$88M-$14M | +$111M-$33M | +$48M-$168M | +$36M-$230M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | XPH PSCH | +21.45%+19.05% | +23.32%+23.19% | +19.10%+21.52% | +20.31%+22.79% |
| Max drawdown | XPH PSCH | -8.11%-13.93% | -17.10%-13.93% | -23.45%-23.50% | -33.10%-47.23% |
| Max drawdown duration | XPH PSCH | 15d80d | 140d80d | 322d449d | 1706d1719d |
XPH | PSCH | |
Last sale 3/12/2026 at 7:59 PM | $53.64 | $40.01 |
| Previous close 03/12/2026 | $55.49 | $41.15 |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
XPH | PSCH | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
XPH | PSCH | |
|---|---|---|
| Last price | $53.64 | $40.01 |
| 1D performance | -3.33% | -2.76% |
| AuM | $302.87 M | $120.40 M |
| E/R | 0.35% | 0.29% |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
